Free Trial

Cronos Group (CRON) Competitors

Cronos Group logo
C$3.11 +0.23 (+7.99%)
As of 08/7/2025 04:00 PM Eastern

CRON vs. BHC, AUP, CARA, SLS, TEV, ABT, NOT, PYR, NVO, and DNA

Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.

Cronos Group vs. Its Competitors

Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

In the previous week, Bausch Health Companies and Bausch Health Companies both had 1 articles in the media. Bausch Health Companies' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Cronos Group is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$6.69B0.31-C$125.65M-C$0.68-11.59
Cronos GroupC$76.86M10.69-C$32.78M-C$0.18-17.31

Bausch Health Companies has a net margin of -1.88% compared to Cronos Group's net margin of -42.65%. Bausch Health Companies' return on equity of 15.87% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-1.88% 15.87% 4.16%
Cronos Group -42.65%-4.40%-3.73%

Bausch Health Companies has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

79.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 16.0% of Cronos Group shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Bausch Health Companies beats Cronos Group on 7 of the 12 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

MetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$821.24MC$2.15BC$5.48BC$6.34B
Dividend YieldN/A2.92%3.99%6.72%
P/E Ratio-17.314.2329.9363.73
Price / Sales10.69674.68375.221,647.33
Price / Cash1.6710.3535.9483.29
Price / Book1.0510.758.104.89
Net Income-C$32.78MC$21.15BC$3.26BC$301.20M
7 Day Performance15.61%0.29%0.68%1.73%
1 Month Performance9.51%2.58%2.45%2.04%
1 Year Performance-1.58%3.21%27.72%30.64%

Cronos Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRON
Cronos Group
N/AC$3.11
+8.0%
N/A+1.6%C$821.24MC$76.86M-17.31450News Coverage
Gap Up
BHC
Bausch Health Companies
N/AC$9.41
-0.4%
N/A+10.0%C$2.45BC$6.69B-13.7719,900Positive News
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading Volume
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
SLS
Solaris Resources
2.0647 of 5 stars
C$6.90
+3.9%
C$12.50
+81.2%
+146.4%C$791.53MN/A-12.0210
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640

Related Companies and Tools


This page (TSE:CRON) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners